한빛사논문 | BRIC

박준식 님의 논문 목록

순천향대학교 의과대학

Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancers
- J. Immunother. Cancer, Jul 04 2024, 12 (7) e009058 | https://doi.org/10.1136/jitc-2024-009058
- 2024-07
- 의약학
- 한빛사논문
Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade
- Clin. Cancer Res., May 14 2024, | https://doi.org/10.1158/1078-0432.CCR-23-2864
- 2024-05
- 의약학
- 한빛사논문
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
- J. Immunother. Cancer, Oct 2023, 11 (10) e007444 | https://doi.org/10.1136/jitc-2023-007444
- 2023-10
- 의약학
- 한빛사논문
4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
- J. Immunother. Cancer, Online issue publication December 16, 2020, 8(2):e001650 | doi: 10.1136/jitc-2020-001650
- 2020-12
- 의약학
- 한빛사논문
Immune Checkpoint Inhibitor-Induced Reinvigoration of Tumor-Infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma
- Clin. Cancer Res., Published Online First : January 18, 2019 | DOI: 10.1158/1078-0432.CCR-18-2564
- 2019-01
- 의약학
- 한빛사논문

저자논문